ArticleRedox biology2026
USP18/DDX5 axis ameliorates mitochondrial morphofunctional damage via OPA1 to inhibit neuronal apoptosis after traumatic brain injury.
Article in Redox biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTraumatic brain injury (TBI) is a leading cause of mortality and morbidity and a major contributor to loss of working capacity in young adults. Current therapeutic options for TBI remain limited. This study aimed to assess the potential role and therapeutic value of ubiquitin-specific protease 18 (USP18) in TBI.
methodsA TBI model was established using the weight-drop model. Neuron-specific Usp18 knockout on the C57BL/6J background was generated by crossbreeding Usp18
resultsMulti-omics analysis of mouse brain and RNA-seq profiling of human brain tissues indicated that the expression of the deubiquitinating enzyme USP18 was substantially decreased in hippocampal neurons. Neuron-specific overexpression of Usp18 via recombinant adeno-associated virus 9 (AAV9) led to reduced neuronal apoptosis and improved cognitive performance in mice. The RNA-seq analysis revealed that Usp18 overexpression enhanced the homeostasis of mitochondrial dynamics, ameliorated neuronal mitochondrial dysfunction, and suppressed oxidative stress injury. These results were also confirmed in a well-established mechanical stretch injury model in HT22 cells. Moreover, compared with control mice, neuron-specific Usp18 knockout mice displayed more severe mitochondrial morphological disarray and neuronal damage after TBI. RNA sequencing, MS analysis, RNA immunoprecipitation sequencing, and RNA immunoprecipitation assays mechanistically revealed that USP18 directly interacted with DEAD-box helicase 5 (DDX5) and deubiquitinated and stabilized DDX5 at the K470 residue (via K48-linked ubiquitination) to increase the stability of the Opa1 mRNA, thereby impeding mitochondrial morphofunctional defects. Collectively, the results of this study reveal the protective effect of and molecular mechanism regulating USP18 in TBI pathology and reveal a novel neuron-specific USP18-DDX5-OPA1 axis involved in TBI.
conclusionsWe identified a USP18-promoted mechanism that maintains the homeostasis of mitochondrial dynamics through the DDX5-OPA1 axis in a TBI model; this pathway inhibits neuronal apoptosis and improves cognitive function in mice, suggesting that USP18 activation or AAV9-Usp18 delivery represents a potential therapeutic strategy for TBI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.